Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Lee

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Gastrointestinal Endoscopy|December 19, 2006
Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopyCynthia W Ko, Stacy Riffle, Jean A Shapiro, et al.
Gastroenterology|November 13, 2019
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative ColitisWilliam J Sandborn, Laurent Peyrin-Biroulet, Jinkun Zhang, et al.
Inflammatory Bowel Diseases|May 20, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trialRemo Panaccione, William J Sandborn, Glenn L Gordon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Inflammatory Bowel Diseases|April 15, 2017
Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's DiseaseWilliam J Sandborn, Douglas C Wolf, Gordana Kosutic, et al.
Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.
Journal of Crohn'S & Colitis|May 31, 2018
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's DiseaseStefan Schreiber, Corey A Siegel, Keith A Friedenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's DiseaseJean-Frédéric Colombel, Bruce E Sands, Christopher Gasink, et al.
Crohn'S & Colitis 360|February 13, 2023
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative ColitisMarla C Dubinsky, Remo Panaccione, James D Lewis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2025
Upadacitinib Maintenance Therapy in Crohn's Disease: Final Results From the Randomized Phase 3 U-ENDURE StudyRemo Panaccione, Miguel Regueiro, Scott D Lee, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Gastrointestinal Endoscopy|December 19, 2006
Incidence of minor complications and time lost from normal activities after screening or surveillance colonoscopyCynthia W Ko, Stacy Riffle, Jean A Shapiro, et al.
Gastroenterology|November 13, 2019
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative ColitisWilliam J Sandborn, Laurent Peyrin-Biroulet, Jinkun Zhang, et al.
Inflammatory Bowel Diseases|May 20, 2015
Briakinumab for treatment of Crohn's disease: results of a randomized trialRemo Panaccione, William J Sandborn, Glenn L Gordon, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 4, 2012
Placental transfer of anti-tumor necrosis factor agents in pregnant patients with inflammatory bowel diseaseUma Mahadevan, Douglas C Wolf, Marla Dubinsky, et al.
Inflammatory Bowel Diseases|April 15, 2017
Effects of Transient and Persistent Anti-drug Antibodies to Certolizumab Pegol: Longitudinal Data from a 7-Year Study in Crohn's DiseaseWilliam J Sandborn, Douglas C Wolf, Gordana Kosutic, et al.
Crohn'S & Colitis 360|February 5, 2024
Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) StudiesMillie D Long, Stefan Schreiber, Toshifumi Hibi, et al.
Journal of Crohn'S & Colitis|May 31, 2018
A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's DiseaseStefan Schreiber, Corey A Siegel, Keith A Friedenberg, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 30, 2023
Evolution of Symptoms After Ustekinumab Induction Therapy in Patients With Crohn's DiseaseJean-Frédéric Colombel, Bruce E Sands, Christopher Gasink, et al.
Crohn'S & Colitis 360|February 13, 2023
Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative ColitisMarla C Dubinsky, Remo Panaccione, James D Lewis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 30, 2025
Upadacitinib Maintenance Therapy in Crohn's Disease: Final Results From the Randomized Phase 3 U-ENDURE StudyRemo Panaccione, Miguel Regueiro, Scott D Lee, et al.
Pageof 5